SCHEMBL891773

SCHEMBL891773

C=CCC(CC=C)C(=O)OCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPA1 P15085 1/20 0.42
ALDH1A1 P00352 4/20 0.40
GRIK1 P39086 2/20 0.39
GRIK2 Q13002 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
CPB2 Q96IY4 1/20 0.38
TSHR P16473 2/20 0.37
ALOX15 P16050 1/20 0.37
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
SOAT1 P35610 1/20 0.37
HCAR2 Q8TDS4 1/20 0.35
TRPA1 O75762 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15114435 0.91 CPA1 (0.40) CPA1ALDH1A1GRIK1GRIK2MEN1
SCHEMBL16063906 0.88 HDAC1 (0.40) CPA1ALDH1A1GRIK1GRIK2MEN1
SCHEMBL31228924 0.88 HDAC1 (0.40) CPA1ALDH1A1GRIK1GRIK2MEN1
SCHEMBL14247855 0.88 CPA1 (0.38) CPA1ALDH1A1GRIK1GRIK2MEN1
SCHEMBL11128669 0.86 MEN1 (0.41) CPA1ALDH1A1GRIK1GRIK2MEN1
SCHEMBL14618365 0.86 GRIK1 (0.38) CPA1ALDH1A1GRIK1GRIK2MEN1
SCHEMBL7175165 0.86 GAA (0.40) CPA1ALDH1A1GRIK1GRIK2MEN1
SCHEMBL5936834 0.86 MEN1 (0.38) CPA1ALDH1A1GRIK1GRIK2MEN1
SCHEMBL4357657 0.85 CA2 (0.46) CPA1ALDH1A1CPB2TSHRGAA
SCHEMBL2158277 0.85 MEN1 (0.37) CPA1ALDH1A1GRIK1GRIK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260007786-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES SPAGO NANOMEDICAL AB (SE) 2026-01-08 US disclosed
EP-4490218-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES Spago Nanomedical AB (SE) 2025-01-15 EP disclosed
CN-118922471-A Compounds for coating nanostructures 斯帕果纳米医学有限公司 2024-11-08 CN disclosed
CN-117810530-A In-situ polymerization high-voltage-resistant semi-solid electrolyte, preparation method thereof and lithium metal semi-solid battery 四川启睿克科技有限公司 2024-04-02 CN disclosed
US-20230399293-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUND AND FLUORINE-CONTAINING COMPOUND AGC Inc. (JP) 2023-12-14 US disclosed
US-20230399471-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUND AND METHOD FOR PRODUCING SURFACE TREATMENT AGENT AGC Inc. (JP) 2023-12-14 US disclosed
US-20230399471-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUND AND METHOD FOR PRODUCING SURFACE TREATMENT AGENT AGC Inc. (JP) 2023-12-14 US disclosed
US-20230392038-A1 COMPOSITION, BASE MATERIAL WITH SURFACE LAYER AND METHOD FOR PRODUCING BASE MATERIAL WITH SURFACE LAYER AGC Inc. (JP) 2023-12-07 US disclosed
WO-2023172185-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES SPAGO NANOMEDICAL AB (SE) 2023-09-14 WO disclosed
EP-4242250-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES Spago Nanomedical AB (SE) 2023-09-13 EP disclosed
EP-1754710-A2 2'-Fluoroncucleosides Emory University (US) 2007-02-21 EP disclosed
US-20060223888-A1 Valproic acid analogues and pharmaceutical composition thereof THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2006-10-05 US disclosed
US-6911424-B2 2′-fluoronucleosides EMORY UNIVERSITY (US) 2005-06-28 US disclosed
US-20040254141-A1 2'-Fluoronucleosides NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-12-16 US disclosed
WO-2004054957-A2 VALPROIC ACID ANALOGUES AND PHARMACEUTICAL COMPOSITIONS THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2004-07-01 WO disclosed
US-20020198171-A1 2'-fluoronucleosides NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-12-26 US disclosed
US-6348587-B1 PURINE OR PYRIMIDINE BASE DERIVATIVES; ANTICANCER, ANTITUMOR AND ANTIPROLIFERATIVE AGENTS; TREATING HIV AND HEPATITIS EMORY UNIVERSITY 2002-02-19 US disclosed
CN-1332747-A 2' -fluoro nucleosides UNIV EMORY (US) 2002-01-23 CN disclosed
EP-1058686-A1 2'-FLUORONUCLEOSIDES EMORY UNIVERSITY (US) 2000-12-13 EP disclosed
WO-1999043691-A1 2'-FLUORONUCLEOSIDES EMORY UNIVERSITY (US) 1999-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198171-A1 2'-fluoronucleosides NSUN2, PNP, FDPS CPA1 1477/4885ALDH1A1 3361/4885GRIK1 4420/4885
US-20040254141-A1 2'-Fluoronucleosides NSUN2, PNP, FDPS CPA1 1477/4885ALDH1A1 3361/4885GRIK1 4420/4885
US-20230399293-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUND AND FLUORINE-CONTAINING COMPOUND AFF1, AFF4, AFF2 CPA1 3310/4885ALDH1A1 1429/4885GRIK1 599/4885
US-20260007786-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES SCO2, PYM1, SSB CPA1 2412/4885ALDH1A1 4535/4885GRIK1 2171/4885
US-20060223888-A1 Valproic acid analogues and pharmaceutical composition thereof MALT1, HDAC11, GABRA6 CPA1 3172/4885ALDH1A1 685/4885GRIK1 144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.